CVS names Joyner as CEO under investor pressure, withdraws profit forecast
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured the company to improve its stagnant share price.
CVS has replaced CEO Karen Lynch with longtime pharmacy benefits executive David Joyner. The company has been struggling to ...
Joyner, who heads CVS’s pharmacy-benefit business Caremark, will succeed Karen Lynch.
Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...
The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...
The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.
CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback